BCAL Diagnostics Limited (ASX:BDX)
Australia · Delayed Price · Currency is AUD 0.0610
-0.0010 (-1.61%)
Aug 6, 2025, 12:39 PM AEST
Lions Gate Entertainment Market Cap
BCAL Diagnostics has a market cap or net worth of 22.69 million as of August 5, 2025. Its market cap has decreased by -48.43% in one year.
Market Cap
22.69M
Enterprise Value
16.98M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 22.69M, a decrease of -56.13%. That is a compound annual growth rate of -18.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 22.69M | -36.08% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
| Jul 21, 2021 | 51.72M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 128.27B |
| Pro Medicus | 32.80B |
| Cochlear | 20.38B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.63B |
| Telix Pharmaceuticals | 6.82B |
| Ansell | 4.36B |
| Mesoblast | 3.01B |